9 hrs agoGold Mountain secures 100% ownership of Brazil JVGold Mountain (ASX:GMN) has completed the acquisition of Mars Mines’ 25% free-carried interest in its Brazil joint venture.Read more
9 hrs agoGold Mountain secures 100% ownership of Brazil JVGold Mountain (ASX:GMN) has completed the acquisition of Mars Mines’ 25% free-carried interest in its Brazil joint venture.Read more
9 hrs agoLithium Energy completes Phase 1 drilling at Burke Graphite ProjectLithium Energy (ASX:LEL) has completed Phase 1 of its resource drilling program at the high-grade Burke Graphite Project.Read more
9 hrs agoLithium Energy completes Phase 1 drilling at Burke Graphite ProjectLithium Energy (ASX:LEL) has completed Phase 1 of its resource drilling program at the high-grade Burke Graphite Project.Read more
9 hrs agoIltani Resources sells non-core Tasmanian tenements to G11 ResourcesSilver and critical minerals explorer Iltani Resources (ASX:ILT) has entered into a tenement sale agreement with G11 Resources (ASX:G11).Read more
9 hrs agoIltani Resources sells non-core Tasmanian tenements to G11 ResourcesSilver and critical minerals explorer Iltani Resources (ASX:ILT) has entered into a tenement sale agreement with G11 Resources (ASX:G11).Read more
10 hrs agoCONNEǪT Health secures $3.1M to fund pulse device growthCONNEǪT Health (ASX:CǪT) has secured $3.1 million (before costs) through a placement of new fully paid ordinary shares at $0.045 per share.Read more
10 hrs agoCONNEǪT Health secures $3.1M to fund pulse device growthCONNEǪT Health (ASX:CǪT) has secured $3.1 million (before costs) through a placement of new fully paid ordinary shares at $0.045 per share.Read more
10 hrs agoS2 Resources completes $17M sale of Fosterville tenementS2 Resources (ASX:S2R) has completed the sale of its Fosterville exploration licence EL007795, held through wholly-owned subsidiary Southern Star Exploration.Read more
10 hrs agoS2 Resources completes $17M sale of Fosterville tenementS2 Resources (ASX:S2R) has completed the sale of its Fosterville exploration licence EL007795, held through wholly-owned subsidiary Southern Star Exploration.Read more
10 hrs agoSaunders International wins $10.4M water project in South West SydneySaunders International (ASX:SND) has secured a $10.4 million contract from Ward Civil to deliver new water storage infrastructure as part of the Wilton Integrated Services Program.Read more
10 hrs agoSaunders International wins $10.4M water project in South West SydneySaunders International (ASX:SND) has secured a $10.4 million contract from Ward Civil to deliver new water storage infrastructure as part of the Wilton Integrated Services Program.Read more
10 hrs agoFOS Capital reports H1 FY26 sales of $12–12.2MFOS Capital (ASX:FOS) has provided a trading and acquisitions update for the first half of FY26, reporting expected sales of $12–12.2 million.Read more
10 hrs agoFOS Capital reports H1 FY26 sales of $12–12.2MFOS Capital (ASX:FOS) has provided a trading and acquisitions update for the first half of FY26, reporting expected sales of $12–12.2 million.Read more
11 hrs agoReece lifts on-market buyback to $85MReece (ASX:REH) has announced a $50 million increase to its on-market share buyback, lifting the total target to $85 million.Read more
11 hrs agoReece lifts on-market buyback to $85MReece (ASX:REH) has announced a $50 million increase to its on-market share buyback, lifting the total target to $85 million.Read more
Tech11 hrs agoNEXTDC shares jump 7% as contracted utilisation rises 30% to 412MWShares in data centre operator NEXTDC (ASX:NXT) rose 7% by midday on Dec. 22 following the announcement of new customer contract wins.Read more
Tech11 hrs agoNEXTDC shares jump 7% as contracted utilisation rises 30% to 412MWShares in data centre operator NEXTDC (ASX:NXT) rose 7% by midday on Dec. 22 following the announcement of new customer contract wins.Read more
11 hrs agoHealth Canada greenlights Neuren Pharmaceuticals' Phase 3 NNZ-2591 trialHealth Canada has approved Neuren Pharmaceuticals' (ASX:NEU) clinical trial application for the Koala Phase 3 clinical trial.Read more
11 hrs agoHealth Canada greenlights Neuren Pharmaceuticals' Phase 3 NNZ-2591 trialHealth Canada has approved Neuren Pharmaceuticals' (ASX:NEU) clinical trial application for the Koala Phase 3 clinical trial.Read more